Search

Displaying results 6781 - 6790 of 7067 in total
  1. Drug

    Sinapic acid

    go.drugbank.com/drugs/DB08587
    Experimental

    Sinapic acid is a matrix for matrix-assisted laser desorption technique for protein MW determination. It is also a constituent of propolis.

    Categories: Compounds used in a research, industrial, or household setting
  2. Drug

    Tryptamine

    go.drugbank.com/drugs/DB08653
    Investigational

    Categories: Monoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substrates
  3. Drug

    7-[(3-CHLOROBENZYL)OXY]-2-OXO-2H-CHROMENE-4-CARBALDEHYDE

    go.drugbank.com/drugs/DB07512
    Experimental

    Categories: Monoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substrates
  4. Drug

    Decyl(dimethyl)phosphine oxide

    go.drugbank.com/drugs/DB07641
    Experimental

    Categories: Monoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substrates
  5. Drug

    Z-Val-Ala-Asp fluoromethyl ketone

    go.drugbank.com/drugs/DB07744
    Experimental

    Non-methylated, competitive, and irreversible inhibitor of caspase 1, as well as other caspases,1 which can be used directly with purified enzymes. It does not require an esterase to hydrolyze the O-methyl ester like the cell-permeable f...

    Categories: Compounds used in a research, industrial, or household setting
  6. Drug

    Hymecromone

    go.drugbank.com/drugs/DB07118
    Investigational

    Categories: Compounds used in a research, industrial, or household setting
  7. Drug

    Gallium citrate

    go.drugbank.com/drugs/DB17893
    Investigational

    Categories: Compounds used in a research, industrial, or household setting
  8. Drug

    24,25-Dihydroxycholecalciferol

    go.drugbank.com/drugs/DB18029
    Experimental

    Synonyms: 24,25-dihydroxyvitamin d3, 24,25-dihydroxyvitamin d 3Categories: Vitamin D and Analogues
  9. Drug

    Quinoline

    go.drugbank.com/drugs/DB18050
    Investigational

    Categories: Monoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substrates
  10. Drug

    Andusomeran

    go.drugbank.com/drugs/DB18227
    ApprovedInvestigational

    Andusomeran is a COVID-19 mRNA vaccine developed for use during the 2023-2024 season.[L40074,L48832,L48837] It is similar to previous mRNA vaccines developed by Moderna (e.g.